After the targets are irradiated they are transported to a Mo-99 processing facility.
Processor Name: MDS NordionLocation: CanadaRelated Reactor: NRUPercent of World Supply: 40%
Processor Name: The Institute for Radio Elements (IRE)Location: BelgiumRelated Reactor: HFR, BR-2, OSIRIS, LVR-15 REZPercent of World Supply: 17%
Processor Name: MallinckrodtLocation: NetherlandsRelated Reactor: HFR, BR-2, MariaPercent of World Supply: 26%
Processor Name: Nuclear Technology Products (NTP)Location: South AfricaRelated Reactor: SAFARI-1Percent of World Supply: 10%
Processor Name: Australian Nuclear Science & Technology Organization (ANSTO)Location: AustraliaRelated Reactor: OPALPercent of World Supply: 3%
Mallinckrodt, the “M” brand mark, and the Mallinckrodt Pharmaceuticals logo are trademarks of a Mallinckrodt company. Other brands are trademarks of a Mallinckrodt company or their respective owners. © 2015 Mallinckrodt.
Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at Damastown, Mulhuddart, Dublin 15, Ireland.